OXGENE, a leader in synthetic biology, is a specialised contract research organisation offering services to support the discovery, development and production of biologics, gene and cell therapies. A unifying theme across the portfolio is expertise in designing DNA, optimising expression of proteins, cell line development, and improving viral delivery systems. OXGENE is headquartered in Oxford, UK.
Location: United Kingdom, England, Oxford
Member count: 51-200
Phone: +44 1865 415107
Total raised: $1.23246M
Founded date: 2011
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 06.05.2020 | - | $1.23246M | Mercia Ass... | mercia.co.... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 21.10.2021 | Spotlight ... | It has been a very successful ... | - | - | mercia.co.... |
| 21.10.2021 | Mercia Ass... | It has been a very successful ... | - | - | marketscre... |
| 10.05.2021 | Julian Vig... | Mercia has solidified its posi... | - | - | mercia.co.... |
| 06.05.2020 | Mercia inv... | OXGENE™ combines precision eng... | - | - | mercia.co.... |